Orange Book product · Generic (ANDA)
CANGRELOR
CANGRELOR
Generic (ANDA)ANDA 213703TE APRX MSN
At a glance
Jun 04, 2026
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 04, 2026
15 d ago
Today
Pharmaceutical detail
Active ingredient
CANGRELOR
Strength
50MG/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
AP
Application
ANDA 213703
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CANGRELOR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
